Ironsides Asset Advisors’s Novartis NVS Stock Holding History

Ironsides Asset Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,130	Closed	-$465K	–	127
2016 Q4	$465K	Buy	7,130 +1,588	+29%	+$103K	0.13%	106
2016 Q3	$392K	Buy	5,542 +393	+8%	+$28.6K	0.11%	117
2016 Q2	$381K	Buy	+5,149	New	+$356K	0.12%	107
2016 Q1	–	Sell	-7,113	Closed	-$548K	–	199
2015 Q4	$548K	Buy	+7,113	New	+$565K	0.15%	96

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ironsides Asset Advisors's NVS Position: Q1 2017 in Review

Ironsides Asset Advisors sold out of Novartis (NVS) in Q1 2017, closing a stake of 7,130 shares — an estimated $465K sold.

Ironsides Asset Advisors first reported a position in NVS in Q4 2015 and held it in 4 quarters. The position peaked at $548K in Q4 2015. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Ironsides Asset Advisors reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
Ironsides Asset Advisors sold 7,130 Novartis shares in Q1 2017, an estimated $465K.
Ironsides Asset Advisors first reported a position in Novartis in Q4 2015 and held it in 4 quarters.
Ironsides Asset Advisors's Novartis position peaked at $548K in Q4 2015.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Ironsides Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.